Launch
Website- Bupa Platinum consultant
-
Fee assured
-
Awaiting
verification
- Open Referral network
Specialises in
- Breast
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
Dr Alison Louise Jones MD FRCP
Consultant Medical Oncologist
Dr Alison Jones graduated from Bristol University in 1980 and after general medical experience she specialised in Medical Oncology, training at the Royal Marsden Hospital where she also undertook a higher degree in Biological Therapy of Cancer for an MD thesis in 1993.
She took up an NHS consultant post in Medical Oncology with Honorary Senior Lecturer status at the Royal Free Hospital in 1993, initially treating a wide range of tumours but subsequently specialising in breast cancer working both at the Royal Free Hospital and University College Hospital, London. She has worked privately in conjunction with her NHS practice for many years and for the last three years has worked in the private sector only, in the context of HCA, mainly at LOC in Harley Street.
During her clinical career she has been active in clinical trials, education, service development and guidelines. She has been chair of her professional society (The Association of Cancer Physicians) for five years and has advised the London Cancer New Drugs Group on introduction of new drugs. She is also a past Vice Chair of CTAAC (Clinical Trials Awards and Advisory Committee) for CRUK. She remains a member of the British Breast Group, ESMO and ASCO.
In her current role she treats women with breast cancer in a multidisciplinary team and attends 2-3 multidisciplinary breast cancer meetings each week. She has an interest in breast cancer from diagnosis, throughout treatment and also has a particular interest in young women with breast cancer, pregnancy associated breast cancer and fertility related issues. Over her career she has taken an interest in medicolegal work and has attended appropriate training and conferences. She has also advised on patent law.
Areas of interest
Breast cancer from early breast cancer to advanced (secondary) disease, including endocrine treatment, chemotherapy and targeted treatment.
Interest in holistic management of side-effects of treatment, including aspects of fertility, pregnancy, menopausal symptoms and bone health.
Personalised medicines and appropriate genetic testing.
Works in context of multidisciplinary team with breast care nurse support for patients.
Medical secretaries
- Alison Fenwick
- LOC (Leaders in Oncology Care) 97 Harley Street London W1G 6AF
- 020 7317 2640
- 020 7009 4241
- afenwick@theloc.com
- Katarina Hunt
- LOC (Leaders in Oncology Care) 97 Harley Street London W1G 6AF
- 020 7317 2640
- 020 7009 4241
- khunt@theloc.com
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (>50)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
-
X3590
Intravenous infusion (as sole procedure) - (>50)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)
-
XR180
Ultrasound guided drainage of fluid collection - (1-5)
-
X3580
Intravenous injection (as sole procedure) - (1-5)